Skip to content

Medhat Rafique Chowdhury, MD

NPI 1386139988ActiveIndividual· Internal Medicine, Interventional Cardiology· Daytona Beach, FL

Internal Medicine, Interventional Cardiology (MD) in Daytona Beach, Florida, licensed in FL, with an NPI issued in June 2018. Part D covered 32 prescriptions written in 2024, 78% of them generic. Abbott Laboratories was the largest of 15 companies reporting payments in 2025, $5,177 in all, mostly food and beverage.

Overview

NPI1386139988
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedJun 26, 2018
Last updated in NPPESJul 3, 2026
Certified by providerJul 3, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (FL)

Part D prescriptions in 2024

Prescriptions (claims)32 · 67 30-day fills
Patients23
Total drug cost$3,463
Generic share78% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$5,177 · 84 payments from 15 companies
  • 2024$1,604 · 33 payments from 15 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$3,703 · 79 payments
  • Travel and Lodging$1,474 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Interventional Cardiology providers in Daytona Beach

All Internal Medicine, Interventional Cardiology providers in Florida →